nps-568 has been researched along with Kidney Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geldyyev, A; Gross-Weissmann, ML; Gut, N; Piecha, G; Potemkina, A; Pradel, A; Regele, H; Ritz, E; Schmitt, CP | 1 |
| Alam, MU; Alexander, MY; Canfield, AE; Kirton, JP; Martin, D; Riccardi, D; Rouhi, M; Sage, AP; Sinha, S; Towers, E; Vizard, TN; Ward, DT; Wilkinson, FL | 1 |
| Ben-Dov, IZ; Naveh-Many, T; Nechama, M; Silver, J | 1 |
| Christopoulos, A; Conigrave, AD; Davey, AE; Leach, K; Sexton, PM; Valant, C | 1 |
| Dikow, R; Gross, ML; Ritz, E | 1 |
| Craig, JC; Elder, G; Messa, P; Palmer, S; Strippoli, GF; Tong, A | 1 |
2 review(s) available for nps-568 and Kidney Diseases
| Article | Year |
|---|---|
Role of calcium-phosphorous disorders in the progression of renal failure.
Topics: Aniline Compounds; Animals; Calcitriol; Calcium; Chronic Disease; Disease Progression; Fibroblast Growth Factor-23; Humans; Hypercalcemia; Hyperthyroidism; Kidney; Kidney Diseases; Kidney Failure, Chronic; Mesangial Cells; Parathyroid Hormone; Parathyroidectomy; Phenethylamines; Phosphates; Podocytes; Propylamines; Vitamin D | 2005 |
Meta-analysis of biochemical and patient-level effects of calcimimetic therapy.
Topics: Aniline Compounds; Calcium; Chronic Disease; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Phenethylamines; Propylamines; Randomized Controlled Trials as Topic | 2006 |
4 other study(ies) available for nps-568 and Kidney Diseases
| Article | Year |
|---|---|
The calcimimetic R-568 prevents podocyte loss in uninephrectomized ApoE-/- mice.
Topics: Albuminuria; Analysis of Variance; Aniline Compounds; Animals; Apolipoproteins E; Apoptosis; Blood Pressure; Calcium; Capillaries; Immunohistochemistry; Kidney Diseases; Kidney Glomerulus; Male; Mice; Mice, Knockout; Myocardium; Nephrectomy; Organ Size; Phenethylamines; Plethysmography; Podocytes; Propylamines; Renin-Angiotensin System; Vitamin D; Vitamins | 2013 |
Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells.
Topics: Aniline Compounds; Animals; Calcinosis; Calcium; Cattle; Cells, Cultured; Chronic Disease; Extracellular Signal-Regulated MAP Kinases; Gadolinium; Humans; Kidney Diseases; Minerals; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenethylamines; Phosphorylation; Propylamines; Receptors, Calcium-Sensing | 2009 |
Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD.
Topics: 3' Untranslated Regions; Adenine; Aniline Compounds; Animals; Calcium; Chronic Disease; Disease Models, Animal; Half-Life; Hyperparathyroidism, Secondary; Kidney Diseases; Lanthanum; Male; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Phosphates; Phosphorus, Dietary; Propylamines; Rats; RNA Stability; RNA-Binding Proteins; RNA, Messenger; Time Factors; Trans-Activators | 2009 |
Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor.
Topics: Allosteric Site; Aniline Compounds; Calcimimetic Agents; Calcium; Cell Membrane; Cinacalcet; HEK293 Cells; Humans; Hyperparathyroidism; Kidney Diseases; Kidney Failure, Chronic; Ligands; Naphthalenes; Phenethylamines; Phosphorylation; Propylamines; Receptors, Calcium-Sensing; Signal Transduction; Treatment Outcome | 2012 |